FGFR1 and ductal breast carcinoma in situ: 2g). These results demonstrate that FOXQ1 plays an important role in the growth of DCIS-iFGFR1 cell-derived tumors; and FOXQ1 upregulation is required for FGFR1 signaling-promoted breast tumor cell proliferating and tumor growth in vivo.